Previous 10 | Next 10 |
EsoGuard/EsoCheck showed pretty slow growth in Q2 but momentum should improve as the company starts targeting consumers and PCPs directly and launches into Europe. Momentum for PAVM's pipeline products remains strong, and the company remains on track to get 3-4 products on the market ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Shares of PAVmed (NASDAQ: PAVM) , a maker of tools for early detection of esophageal and pancreatic cancer, were down more than 15% as of 11:35 a.m. EDT today after the company reported earnings yesterday afternoon. Image source: Getty Images. For the six months ended June 3...
PAVmed Inc. (PAVM) Q2 2021 Earnings Conference Call August 12, 2021, 04:30 PM ET Company Participants Mike Havrilla - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Conference Call Participants Frank Takkinen - Lake Street Capital Ed Woo - Ascendiant Capital...
Conference call to be held today at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today provided a business update for the Compa...
Patients undergoing esophageal precancer testing at centers in Phoenix metro area PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announ...
PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present...
PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that prominent global industry executive Aster Angagaw has joined the Board of Directors o...
Company conference call and webcast at EDT 4:30PM EDT First paragraph, first sentence of release should read: ...Thursday, August 12, 2021, at 4:30 PM EDT (instead of Monday, August 12, 2021, at 4:30 PM EDT). The updated release reads: PAVMED TO HOLD BUSINESS UPDAT...
Company conference call and webcast at EDT 4:30PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...